Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

AVEO Reports First Quarter 2010 Financial Results

Aveo Oncology 04.29.2010

AVEO Pharmaceuticals Receives Milestone Payment from Biogen Idec under Licensing Agreement for ErbB3 Antibody Program

Aveo Oncology 04.14.2010

AVEO Pharmaceuticals, Inc. Completes Initial Public Offering

Aveo Oncology 03.18.2010

AVEO Pharma Sets IPO Terms

Aveo Oncology 02.23.2010

AVEO Pharmaceuticals Files Registration Statement for Initial Public Offering

Aveo Oncology 12.16.2009

OSI Pharmaceuticals and AVEO Pharmaceuticals Expand Oncology Discovery and Translational Research Collaboration

Aveo Oncology 07.21.2009

AVEO Pharmaceuticals’ Scientific Advisory Board Members Recognized for Contributions to Cancer Research and Medicine

Aveo Oncology 05.13.2009

AVEO and Biogen Idec Form Strategic Alliance for Development and Commercialization of ErbB3-Targeted Antibodies

Aveo Oncology 03.24.2009

AVEO Pharmaceuticals and Merck Sign Collaboration for Clinical Drug Response Predicition

Aveo Oncology 11.02.2005

GENPATH PHARMACEUTICALS BECOMES AVEO PHARMACEUTICALS

Aveo Oncology 03.01.2005

Loading